Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Dec 05, 2020 12:24pm
119 Views
Post# 32043982

RE:RE:RE:RE:RE:RE:RE:RE:Ceapro % Ownership

RE:RE:RE:RE:RE:RE:RE:RE:Ceapro % OwnershipUser2020,

For longer term shareholders, one can definitely appreciate the work that Gilles has done.  Essentially saved the company likely from bankruptcy and turned it around. Financial stability as a result of the base business has allowed it to "snatch" a disruptive technology and now PGX is on the cusp of commercialization. 

As you noted,Gilles did not promote PGX for the extraction of cannabinoids.  Gilles realized the cannabis craze was not sustainable and was not where he wanted to take PGX.  That irked many analysts (ie. Fabrice Taylor) and other shareholders who wanted a quick run up in the share price. Some said a quick run up would allow CZO the tap the capital markets for leaner times.  Seems like CZO did not need the cash thus far and GIlles reluctance to pander to Bay Street isolated the company.

If PGX pans out, Gilles resolute vision for PGX will be vindicated and those of us still here will be handsomely rewarded (at least that's the fairytale ending).

<< Previous
Bullboard Posts
Next >>